View on Pubmed.gov 36378489 | View on doi.org 10.1128/msystem...
TaxiBGC: a Taxonomy-Guided Approach for Profiling Experimentally Characterized Microbial Biosynthetic Gene Clusters and Secondary Metabolite Production Potential in Metagenomes.
- Microbiome Program, Center for Individualized Medicine, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.
- Division of Surgery Research, Department of Surgery, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.
- Institute of Health Sciences, Presidency University, Kolkata, West Bengal, India.
- Department of Computer Science and Engineering, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA.
- Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota-Twin Cities, St. Paul, Minnesota, USA.
- BioTechnology Institute, University of Minnesota-Twin Cities, St. Paul, Minnesota, USA.
- Division of Rheumatology, Department of Medicine, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
- Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan, USA.
- Center for Bioinformatics and Computational Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Abstract
Biosynthetic gene clusters (BGCs) in microbial genomes encode bioactive secondary metabolites (SMs), which can play important roles in microbe-microbe and host-microbe interactions. Given the biological significance of SMs and the current profound interest in the metabolic functions of microbiomes, the unbiased identification of BGCs from high-throughput metagenomic data could offer novel insights into the complex chemical ecology of microbial communities. Currently available tools for predicting BGCs from shotgun metagenomes have several limitations, including the need for computationally demanding read assembly, predicting a narrow breadth of BGC classes, and not providing the SM product. To overcome these limitations, we developed onomy-guided dentification of iosynthetic ene lusters (TaxiBGC), a command-line tool for predicting experimentally characterized BGCs (and inferring their known SMs) in metagenomes by first pinpointing the microbial species likely to harbor them. We benchmarked TaxiBGC on various simulated metagenomes, showing that our taxonomy-guided approach could predict BGCs with much-improved performance (mean F score, 0.56; mean PPV score, 0.80) compared with directly identifying BGCs by mapping sequencing reads onto the BGC genes (mean F score, 0.49; mean PPV score, 0.41). Next, by applying TaxiBGC on 2,650 metagenomes from the Human Microbiome Project and various case-control gut microbiome studies, we were able to associate BGCs (and their SMs) with different human body sites and with multiple diseases, including Crohn's disease and liver cirrhosis. In all, TaxiBGC provides an platform to predict experimentally characterized BGCs and their SM production potential in metagenomic data while demonstrating important advantages over existing techniques. Currently available bioinformatics tools to identify BGCs from metagenomic sequencing data are limited in their predictive capability or ease of use to even computationally oriented researchers. We present an automated computational pipeline called TaxiBGC, which predicts experimentally characterized BGCs (and infers their known SMs) in shotgun metagenomes by first considering the microbial species source. Through rigorous benchmarking techniques on simulated metagenomes, we show that TaxiBGC provides a significant advantage over existing methods. When demonstrating TaxiBGC on thousands of human microbiome samples, we associate BGCs encoding bacteriocins with different human body sites and diseases, thereby elucidating a possible novel role of this antibiotic class in maintaining the stability of microbial ecosystems throughout the human body. Furthermore, we report for the first time gut microbial BGC associations shared among multiple pathologies. Ultimately, we expect our tool to facilitate future investigations into the chemical ecology of microbial communities across diverse niches and pathologies.
References
Appl Transl Genom. 2016 Feb 05;10:10-5
Nat Med. 2019 Apr;25(4):679-689
PLoS Pathog. 2020 Apr 9;16(4):e1008370
Trends Microbiol. 2007 Jan;15(1):22-30
Cited by 6 citations (total)
Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural
GMWI-webtool: a user-friendly browser application for assessing health through metagenomic gut microbiome profiling.
Electronic publication date February 8, 2023
Daniel Chang [...] Jaeyun Sung et al.
SUMMARY
We recently introduced the Gut Microbiome Wellness Index (GMWI), a stool metagenome-based indicator for assessing health by determining the likelihood...
Journal Article Review
New approaches to secondary metabolite discovery from anaerobic gut microbes.
Electronic publication date January 20, 2025
Lazarina V Butkovich [...] Michelle A O'Malley et al.
The animal gut microbiome is a complex system of diverse, predominantly anaerobic microbiota with secondary metabolite potential. These metabolites likely...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •